National BBV & STI Surveillance and Monitoring Reports

These executive summaries provide an annual account of progress against the objectives of Australia’s National Blood borne Virus (BBV) and Sexually Transmissible Infections (STIs) Strategies. The targets and associated objectives of the National Strategies are to improve testing, treatment and uptake of preventative measures for hepatitis B, hepatitis C, STIs and HIV, and to reduce the incidence, morbidity, mortality and personal and social impacts they cause. Each objective has a series of measurable indicators for monitoring progress.

These executive summaries provide an annual account of progress against the objectives of Australia’s National Blood borne Virus (BBV) and Sexually Transmissible Infections (STIs) Strategies. The targets and associated objectives of the National Strategies are to improve testing, treatment and uptake of preventative measures for hepatitis B, hepatitis C, STIs and HIV, and to reduce the incidence, morbidity, mortality and personal and social impacts they cause. Each objective has a series of measurable indicators for monitoring progress.

These executive summaries provide an annual account of progress against the objectives of Australia’s National Blood borne Virus (BBV) and Sexually Transmissible Infections (STIs) Strategies. The targets and associated objectives of the National Strategies are to improve testing, treatment and uptake of preventative measures for hepatitis B, hepatitis C, STIs and HIV, and to reduce the incidence, morbidity, mortality and personal and social impacts they cause. Each objective has a series of measurable indicators for monitoring progress.

This report provides an annual account of progress against the objectives of Australia’s National blood‑borne virus (BBV) and sexually transmissible infections (STIs) Strategies.

In June 2014, Australia’s federal, state and territory health ministers endorsed five new National Strategies for hepatitis B, hepatitis C, STIs, and human immunodeficiency virus (HIV) together with a National Aboriginal and Torres Strait Islander BBV and STI Strategy.

This report provides an annual account of progress against the goals and objectives of Australia’s National Blood‑Borne Virus (BBV) and Sexually Transmissible Infections (STIs) Strategies.

In June 2014, Australia’s federal, state and territory health ministers endorsed five new National Strategies for hepatitis B, hepatitis C, STIs, and human immunodeficiency virus (HIV) together with a National Aboriginal and Torres Strait Islander BBV and STI Strategy.

This report provides an annual account of progress against the goals and objectives of Australia’s National Blood‑Borne Virus (BBV) and Sexually Transmissible Infections (STIs) Strategies.

In April 2010, a suite of National Strategies for the prevention and management of Human Immunodeficiency Virus (HIV), sexually transmissible infections, hepatitis B and hepatitis C, including in Aboriginal and Torres Strait
Islander communities were endorsed by the Australian Health Ministers’ Conference. The National Strategies cover the period 2010 – 2013.

This report provides an annual account of progress against the goals and objectives of Australia’s National Blood‑Borne Virus (BBV) and Sexually Transmissible Infections (STIs) Strategies.

In April 2010, a suite of National Strategies for the prevention and management of Human Immunodeficiency Virus (HIV), sexually transmissible infections, hepatitis B and hepatitis C, including in Aboriginal and Torres Strait
Islander communities were endorsed by the Australian Health Ministers’ Conference. The National Strategies cover the period 2010 – 2013.